Video March 6, 2010 0 IMUC: Immunotherapy On Multiple Fronts In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
Uncategorized January 14, 2010 0 [OneMedForum] Immunocellular Therapeutics The Los Angeles-based company discussed its recent clinical trials, including results from a Phase I study of ICT-107 to treat a deadly form of brain cancer called glioblastoma.
